Cargando…
A case report of psoriasis flare following immunotherapy: Report of an important entity and literature review
Immune checkpoint inhibitors, such as anti-cytotoxic T-lymphocyte–associated antigen-4 and anti-programmed death-1, are a type of cancer immunotherapy approved for late-stage malignancy treatment. However, such therapies often induce immune-related adverse events. During anti-programmed death-1 bloc...
Autores principales: | Politi, Anastasia, Angelos, Dimas, Mauri, Davide, Zarkavelis, George, Pentheroudakis, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958646/ https://www.ncbi.nlm.nih.gov/pubmed/31976071 http://dx.doi.org/10.1177/2050313X19897707 |
Ejemplares similares
-
Primary Pulmonary Malignant Melanoma: Report of an Important Entity and Literature Review
por: Kyriakopoulos, Christos, et al.
Publicado: (2017) -
How I treat cancers of unknown primary
por: Zarkavelis, George, et al.
Publicado: (2019) -
The cancer immunotherapy environment may confound the utility of anti-TIF-1γ in differentiating between paraneoplastic and treatment-related dermatomyositis. Report of a case and review of the literature
por: Zarkavelis, George, et al.
Publicado: (2020) -
Case of resolution of plaque psoriasis following treatment with rifampicin for latent tuberculosis: A case report
por: Muntyanu, Anastasiya, et al.
Publicado: (2023) -
Plaque psoriasis and morphea in a patient on ustekinumab: A case report
por: Cirone, Katrina, et al.
Publicado: (2023)